Cyramza (ramucirumab) is a medication that is given by injection and is used to treat certain types of cancer, including advanced gastric or gastroesophageal junction (GEJ) cancer, non-small cell lung cancer (NSCLC), and colorectal cancer. It works by blocking a protein that helps cancer cells grow and spread.
The typical dosage of Cyramza is 8 mg per kilogram of body weight, given once every two weeks as an intravenous (IV) infusion. The dose may be adjusted based on your response to the medication and any side effects you may experience.
The medication is given by a healthcare professional in a hospital or clinic setting. It is important to follow your doctor's instructions and attend all scheduled appointments for Cyramza infusions.
As with all medications, Cyramza may cause side effects. Common side effects may include high blood pressure, fatigue, diarrhea, decreased appetite, and mouth sores. More serious side effects may include bleeding, blood clots, and perforation of the stomach or intestines. If you experience any concerning symptoms or side effects, be sure to speak with your doctor as soon as possible.